S. Abbot

Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma

Z. An, M. Tabrizizad, A. Lucas, 2021, Journal for ImmunoTherapy of Cancer.

Altered growth phenotype of a Burkitt's lymphoma line following the introduction and stable expression of the EBNA 2A gene.

E. Kieff, G. Guy, A. Rickinson, 1988, Current topics in microbiology and immunology.

Normal and neoplastic human plasma cells express bcl-2 antigen.

H. F. Barker, I. Franklin, M. Hamilton, 1991, Leukemia.

Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein

M. Rowe, A. Rickinson, J. Gordon, 1990, Journal of virology.

IL-2 expands and maintains IgM plasmablasts from a CD5+ subset contained within the germinal centre cell-enriched (surface IgD-/CD39- buoyant) fraction of human tonsil.

I. Maclennan, M. Holder, J. Gordon, 1993, International immunology.

119 ADI-002: an IL-15 armored allogeneic ‘off-the-shelf’ Vδ1 gamma delta CAR T cell therapy for solid tumors targeting glypican-3 (GPC3)

A. Lucas, Z. An, M. Tabrizizad, 2021, Journal for ImmunoTherapy of Cancer.